Lifespan and ath434, page-10

Most likely they will report a "preliminary annual report" at the end of Aug. Last year we got it on the 31st of Aug. Final Annual report was published on the 9th of Sep. We need to get info about PBT2 in antibiotic-resistant infections, where are we in saving 700.000 lives each year.

I hope there will be other announcements before September. There are many publications about PBT2 and ATH434 without any comments: Kosman paper about endothelium, Fusobacterium and PBT2 paper by a New Zealand group, and ATH434 gut propulsion paper by Finkelstein et al.

Kosman's paper is perhaps the most important because it relates so well to how atherosclerosis starts. Fusobacterium infection is connected with colorectal cancer and its progression and got propulsion paper demonstrates how gut improves with ATH434 in an animal model of PD. Obstipation is a big problem in PD. All important issues but no comment by the administration. Perhaps these will be in the annual report.